Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection

Por Nunes, J, Naymark, M, Sauer, L, Muhammad, A, Keun, H, Sturge, J, Stebbing, J, Waxman, J, Pchejetski, D
Publicado em 2012

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study

Por Henry, N L, Pchejetski, D, A'Hern, R, Nguyen, A T, Charles, P, Waxman, J, Li, L, Storniolo, A M, Hayes, D F, Flockhart, D A, Stearns, V, Stebbing, J
Publicado em 2010

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer

Por Annels, N E, Simpson, G R, Denyer, M, McGrath, S E, Falgari, G, Killick, E, Eeles, R, Stebbing, J, Pchejetski, D, Cutress, R, Murray, N, Michael, A, Pandha, H
Publicado no Clin Exp Immunol (2014)